These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20562778)

  • 1. Psychiatrists between personal freedom to prefer antipsychotic in treatment of schizophrenic patients and algorithms and guidelines.
    Loga S; Loga-Zec S
    Psychiatr Danub; 2010 Jun; 22(2):343-5. PubMed ID: 20562778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to manage in current treatment of schizophrenic patients.
    Loga S
    Psychiatr Danub; 2007 Dec; 19(4):359-61. PubMed ID: 18000489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia treatment guidelines in the United States.
    Moore TA
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):40-9. PubMed ID: 21459738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing treatment guidelines.
    Miller AL
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):15-6. PubMed ID: 21459734
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-world antipsychotic treatment practices.
    Moore TA; Covell NH; Essock SM; Miller AL
    Psychiatr Clin North Am; 2007 Sep; 30(3):401-16. PubMed ID: 17720029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
    Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
    Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].
    Delessert D; Pomini V; Grasset F; Baumann P
    Encephale; 2008 Jan; 34(1):93-100. PubMed ID: 18514156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L; Nielsen B; Stage KB; Brøsen K; Damkier P
    Nord J Psychiatry; 2008; 62(3):242-9. PubMed ID: 18622885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our knowledge is patchwork. Survey on the adherence to international guidelines concerning acute and long-term therapy in recurrent depressions and diseases in the schizophrenic field].
    Ramseier F
    Praxis (Bern 1994); 1996 Jun; 85(24):792-7. PubMed ID: 8701169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a Polish national survey--physician's opinions on the physical health of schizophrenic patients].
    Kiejna A; Czernikiewicz A; Adamowski T
    Psychiatr Pol; 2009; 43(6):761-73. PubMed ID: 20209887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do large scale studies of medication in schizophrenia add to our management strategies?
    Agius M; Davis A; Gilhooley M; Chapman S; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):323-8. PubMed ID: 20562774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Cobaugh DJ; Erdman AR; Booze LL; Scharman EJ; Christianson G; Manoguerra AS; Caravati EM; Chyka PA; Woolf AD; Nelson LS; Troutman WG
    Clin Toxicol (Phila); 2007 Dec; 45(8):918-42. PubMed ID: 18163235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.